I'm closely following the information on KOSTAIVE®, but they are hiding the vaccination number.
Since the specific number is unknown, I cannot say anything rash, but I suspect the number is much lower than we expect. Meiji Seika Pharma is suing Councilman Haraguchi for defamation, and the report at the press conference was as follows.
-The target age group is 65 and over since October 2024
-Initial shipment of 4.27 million doses is planned
-KOSTAIVE® sales forecast is 10.5 billion yen
-Actual sales are 0.37 billion yen (December 2024)
I think the vaccination number will be announced in the near future, so I will update it as it comes.
thank you Patent Sun,
I follow your X posts closely: @Patent_SUN
This report should have caused a product recall in a sane regulatory environment
.. but we do need to know how many doses were administered
even then, they will label these deaths as 'rare'
not rare for those who died - pretty unique and far from rare, in fact, for each victim
.. but they took this drug to stop an illness (Covid-19) with survival chances significantly exceeding >99%
Thank you for your comment.
I'm closely following the information on KOSTAIVE®, but they are hiding the vaccination number.
Since the specific number is unknown, I cannot say anything rash, but I suspect the number is much lower than we expect. Meiji Seika Pharma is suing Councilman Haraguchi for defamation, and the report at the press conference was as follows.
-The target age group is 65 and over since October 2024
-Initial shipment of 4.27 million doses is planned
-KOSTAIVE® sales forecast is 10.5 billion yen
-Actual sales are 0.37 billion yen (December 2024)
I think the vaccination number will be announced in the near future, so I will update it as it comes.